Product Name:Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester
IUPAC Name:2-(pyridine-4-carbonyloxy)ethyl pyridine-4-carboxylate
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM314472-1g | in stock | Ɠľ |
|
| CM314472-5g | in stock | ƿǪƿ |
|
|
|||
| Product Overview |
Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester, also known as ethyl 4-(pyridine-4-carbonyloxy)isonicotinate, is an organic compound that has been widely used in scientific research. This compound is a derivative of isoniazid, a well-known anti-tuberculosis drug. |
| Physical Properties |
It has high solubility in water and organic solvents. |
| Chemical Properties |
It is low toxicity, and its ability to modulate various cellular processes. The limitations of using this compound include its high cost and the limited availability of commercial sources. |
| Synthesis and Application |
1. Cancer research: Isonicotinic acid 2-(pyridine-4-carbonyloxy)-Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester ester has been found to exhibit anti-cancer activity by inducing apoptosis (programmed cell death) in cancer cells. This compound has been studied as a potential anti-cancer agent for various types of cancer, including lung cancer, breast cancer, and leukemia. 2. Neurodegenerative disease research: Isonicotinic acid 2-(pyridine-4-carbonyloxy)-Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester ester has been found to have neuroprotective effects and has been studied as a potential treatment for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. 3. Antimicrobial research: Isonicotinic acid 2-(pyridine-4-carbonyloxy)-Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester ester has been found to exhibit antimicrobial activity against various bacterial and fungal strains, including Staphylococcus aureus and Candida albicans. |
| Future Directions |
1.Further studies are needed to elucidate the mechanism of action of isonicotinic acid 2-(pyridine-4-carbonyloxy)-Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester ester. 2. The potential of this compound as a therapeutic agent for various diseases should be further explored. 3. The development of more efficient and cost-effective synthesis methods for this compound should be investigated. 4. The use of isonicotinic acid 2-(pyridine-4-carbonyloxy)-Isonicotinic acid 2-(pyridine-4-carbonyloxy)-ethyl ester ester in combination with other compounds should be explored to enhance its therapeutic potential. 5. The potential of this compound as a diagnostic tool for various diseases should be investigated. |
Search 
+86 21 5895 0110 
